| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/21/2013 | WO2013024589A1 Prophylactic agent and/or therapeutic agent for sepsis |
| 02/21/2013 | WO2013024495A1 Pharmaceutical formulations of cabazitaxel |
| 02/21/2013 | WO2013024494A2 Amorphous mixture of lopinavir and ritonavir co-precipitated on copovidone |
| 02/21/2013 | WO2013024493A1 C-9 oxygen functionalized labdane derivates |
| 02/21/2013 | WO2013024487A1 Anti- vitiligo composition |
| 02/21/2013 | WO2013024474A1 Polymorphs of preladenant |
| 02/21/2013 | WO2013024467A2 Mitochondrial ribosomal proteins as aging regulators |
| 02/21/2013 | WO2013024447A1 Compounds for use in cancer therapy |
| 02/21/2013 | WO2013024427A1 Novel urea derivatives as tec kinase inhibitors and uses thereof |
| 02/21/2013 | WO2013024425A1 Combinations of corroles and statins |
| 02/21/2013 | WO2013024411A1 Co-milled formulation of dronedarone |
| 02/21/2013 | WO2013024376A1 Compositions and methods for the treatment of atherothrombosis |
| 02/21/2013 | WO2013024373A1 Pharmaceutical composition comprising cefuroxime |
| 02/21/2013 | WO2013024324A1 [Cu(thp)4]n[X]-n COMPOUNDS FOR THE TREATMENT OF A BROAD RANGE OF HUMAN SOLID TUMORS, INCLUDING REFRACTORY TUMORS |
| 02/21/2013 | WO2013024320A1 2, 6 xylidine derivatives for the treatment of pain |
| 02/21/2013 | WO2013024312A1 A pharmaceutical composition for the treatment of stem cells |
| 02/21/2013 | WO2013024311A1 Amidoxime derivatives for the prevention and/or treatment of muscle atrophy |
| 02/21/2013 | WO2013024291A2 Therapeutically active fused pyrimidine derivatives |
| 02/21/2013 | WO2013024282A2 Compounds and their uses |
| 02/21/2013 | WO2013024174A1 Dha triglyceride, dha free fatty acid, and dha ethyl ester emulsions, and methods of treating spinal cord injury |
| 02/21/2013 | WO2013024171A1 Carbamoylmethoxy- and carbamoylmethylthio- and carbamoylmethylamino benzamides for combating invertebrate pests |
| 02/21/2013 | WO2013024170A1 Carbamoylmethoxy- and carbamoylmethylthio- and carbamoylmethylamino benzamides for combating invertebrate pests |
| 02/21/2013 | WO2013024168A1 Piperazine thiazole derivatives useful in the treatment of tauopathies such as alzheimer's disease |
| 02/21/2013 | WO2013024164A1 Combinations of a 5-ht4 receptor agonist and a pde4 inhibitor for use in therapy |
| 02/21/2013 | WO2013024158A1 Combinations of protein kinase inhibitors and interferons or of protein kinase inhibitors and direct acting antivirals for the treatment and the prevention of hcv infection |
| 02/21/2013 | WO2013024149A1 Crystalline forms of octahydro-3h-spiro [furo [3, 4-c] quinoline -1, 4 '-pyran] -9-ol |
| 02/21/2013 | WO2013024130A1 Furo[3,4-c]quinoline derivatives, medicaments containing such compounds, their use and process for their preparation |
| 02/21/2013 | WO2013024104A1 4-(8-methoxy-1-((1-methoxypropan-2-yl)-2-(tetrahydro-2h-pyran-4-yl)-1 h-imidazo[4,5-c]quinolin-7-yl)-3,5-dimethylisoxazole and its use as bromodomain inhibitor |
| 02/21/2013 | WO2013024078A1 Inhibitors of bruton's tyrosine kinase |
| 02/21/2013 | WO2013024070A1 Pharmaceutical aerosol product for administration by oral or nasal inhalation |
| 02/21/2013 | WO2013024067A1 Use of antioxidants for improving animal health |
| 02/21/2013 | WO2013024053A1 Carrier-linked prodrugs having reversible carboxylic ester linkages |
| 02/21/2013 | WO2013024051A1 Sustained release composition of prostacyclin |
| 02/21/2013 | WO2013024036A1 Funny current (if) inhibitors for use in a method of treating and preventing heart failure in feline |
| 02/21/2013 | WO2013024035A1 Folate conjugates of albumin-binding entities |
| 02/21/2013 | WO2013024028A1 Compounds and compositions for treating proteinopathies |
| 02/21/2013 | WO2013024023A1 Taste masked pharmaceutical composition |
| 02/21/2013 | WO2013024012A1 Medicinal skin protection composition with an active ingredient combination which improves the skin barrier |
| 02/21/2013 | WO2013024011A1 Indazole compounds, compositions and methods of use |
| 02/21/2013 | WO2013024010A1 N-thio-anthranilamide compounds and their use as pesticides |
| 02/21/2013 | WO2013024004A1 N-thio-anthranilamide compounds and their use as pesticides |
| 02/21/2013 | WO2013024002A1 PYRAZOLO[3,4-c]PYRIDINE COMPOUNDS AND METHODS OF USE |
| 02/21/2013 | WO2013023982A1 Novel compounds for the treatment of inflammatory bowel disease |
| 02/21/2013 | WO2013023970A1 Pharmaceutical composition comprising 4-[4[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-n-methylpyridine-2-carboxamide |
| 02/21/2013 | WO2013023882A1 Uridine and uridine analogues for treatment of specific lung diseases, namely copd and pulmonary fibrosis |
| 02/21/2013 | WO2013023856A1 Use of a polysaccharide polymer from the seeds of the tamarind seed in protecting against tobacco-associated damages |
| 02/21/2013 | WO2013023826A1 Edible composition comprising sterol |
| 02/21/2013 | WO2013023622A1 Acylated derivative of homoharringtonine, preparation method therefor, and application thereof |
| 02/21/2013 | WO2013023620A1 Aminated derivative of homoharringtonine, preparation method therefor, and application thereof |
| 02/21/2013 | WO2013023615A1 Use of vanillic acid glycoside derivatives for treating systemic autoimmune disease |
| 02/21/2013 | WO2013023563A1 Use of potassium piperonyl pentadienoate for lowering blood lipid |
| 02/21/2013 | WO2013023540A1 Triazine compound and use thereof in control of chicken coccidiosis |
| 02/21/2013 | WO2013023511A1 Triazolopyrimidine derivative and preparation method and use thereof |
| 02/21/2013 | WO2013023439A1 Salt and polymorph of pyrazolopyrimidinone compound and drug composition, preparation method and use thereof |
| 02/21/2013 | WO2013023340A1 Honeysuckle extract, and pharmaceutical composition comprising the same and use of the same |
| 02/21/2013 | WO2013023339A1 Secologanolic acid, pharmaceutical composition comprising same and use thereof |
| 02/21/2013 | WO2013023338A1 Pharmaceutical composition containing honeysuckle extract and antibiotics, pharmaceutical kit, and use of honeysuckle extract for preparation of drug |
| 02/21/2013 | WO2013023319A1 In vitro method for modifying the depletion profile of treg cells present in a total splenocyte population of a biological sample by means of the isolation, culturing and exposure thereof to an atp and polymixin b medium |
| 02/21/2013 | WO2013023300A1 Inhibitors of androgen receptor activation function-2 (af2) as therapeutics and methods for their use |
| 02/21/2013 | WO2013023274A1 Substituted 2-imidazolidinones and 2-imidazolones and their use in the treatment of cancer |
| 02/21/2013 | WO2013023273A1 Piperazine derivatives |
| 02/21/2013 | WO2013023251A1 Soluble polypeptides |
| 02/21/2013 | WO2013023250A1 Controlled-release formulation |
| 02/21/2013 | WO2013002485A3 Pharmaceutical composition for preventing and treating kidney disorders, containing inhibitor for phosphorylation of taz tyrosine as active ingredient for activation of nfat5/tonebp |
| 02/21/2013 | WO2013000895A9 Dha and epa in the reduction of oxidative stress |
| 02/21/2013 | WO2012177856A3 Cognition modification |
| 02/21/2013 | WO2012176163A3 Compounds for the treatment of cancers associated with human papillomavirus |
| 02/21/2013 | WO2012174549A9 Blockade of eosinophil production by toll-like receptors |
| 02/21/2013 | WO2012174224A3 Methods for administering nucleic acid-based therapeutics |
| 02/21/2013 | WO2012170952A9 Compounds for targeting drug delivery and enhancing sirna activity |
| 02/21/2013 | WO2012170947A3 Methods for modulating factor 12 expression |
| 02/21/2013 | WO2012170931A3 Compounds that modulate intracellular calcium |
| 02/21/2013 | WO2012170839A3 Treatment of neuroinflammatory disease with selective cox1 inhibitors |
| 02/21/2013 | WO2012166951A9 Novel glp-1 receptor stabilizers and modulators |
| 02/21/2013 | WO2012166938A3 (22e)-2-methylene-26,27-cyclo-22-dehydro-1alpha-hydroxy-19-norvitamin d3 derivatives |
| 02/21/2013 | WO2012166716A3 Subsituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating hcv infections |
| 02/21/2013 | WO2012166614A9 Thiocarbamate and sulfonamide hydroxamate inhibitors of insulin-degrading enzyme |
| 02/21/2013 | WO2012162394A3 Compositions and methods for treating renal disease |
| 02/21/2013 | WO2012156296A8 Pharmaceutical combination for use in inducing weight loss in diabetes type 2 patients or/and for preventing weight gain in diabetes type 2 patients |
| 02/21/2013 | WO2012154680A3 MODIFIED AND DERIVATIZED β-GLUCAN COMPOUNDS, COMPOSITIONS, AND METHODS |
| 02/21/2013 | WO2012154271A3 Method and cells for identifying rig-i pathway regulators |
| 02/21/2013 | WO2012149186A9 Novel bisaminoquinoline compounds, pharmaceutical compositions prepared therefrom and their use |
| 02/21/2013 | WO2012141536A3 Composition for regenerating connective tissue, and method for regenerating connective tissue |
| 02/21/2013 | WO2012134231A3 Benzamide derivative as cannabinoid receptor (cb1) antagonist |
| 02/21/2013 | WO2012090204A8 2 - (2 - phenylethenyl) - 1, 3 -benzothiazine derivatives useful for the treatment of cancer |
| 02/21/2013 | WO2012065139A3 Entpd5 inhibitors |
| 02/21/2013 | WO2012026897A9 A process for the preparation of imatinib base |
| 02/21/2013 | WO2012022120A8 Dihydropyrazole compounds |
| 02/21/2013 | WO2012013020A8 Anti-fatigue composition, formulation and use thereof |
| 02/21/2013 | WO2011158175A3 Polyphenol derivative composition and uses thereof as bactericide and fungicide |
| 02/21/2013 | WO2011101828A8 A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer and betamethasone, and a process to make it |
| 02/21/2013 | WO2011101069A3 1, 8 -naphthyridines as kinase inhibitors |
| 02/21/2013 | US20130046283 Methods and intravascular treatment devices for treatment of atherosclerosis |
| 02/21/2013 | US20130046275 Material and method for treating internal cavities |
| 02/21/2013 | US20130046240 Bepotastine compositions |
| 02/21/2013 | US20130046026 Composition with improved skin penetration for transdermal delivery of tolterodine |
| 02/21/2013 | US20130046025 Composition with low skin irritation for transdermal delivery of tolterodine |
| 02/21/2013 | US20130046023 Pharmaceutical composition containing glur2-lacking ampar antagonist for preventing or treating psychiatric illnesses |
| 02/21/2013 | US20130046022 Gel composition for treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt |
| 02/21/2013 | US20130046021 Methods of treating cardiomyopathy, systolic cardiac dysfunction and the symptoms of congestive heart failure with probenecid |